CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $275,000 | -12.4% | 517,806 | +800.7% | 0.04% | 0.0% |
| Q4 2019 | $314,000 | +307.8% | 57,488 | +265.2% | 0.04% | +270.0% |
| Q3 2019 | $77,000 | -40.3% | 15,742 | -7.9% | 0.01% | +42.9% |
| Q3 2018 | $129,000 | -81.7% | 17,100 | -87.7% | 0.01% | -80.0% |
| Q2 2018 | $704,000 | +49.2% | 139,500 | +109.8% | 0.04% | +20.7% |
| Q4 2017 | $472,000 | -34.5% | 66,500 | -34.0% | 0.03% | -40.8% |
| Q3 2017 | $721,000 | +94.9% | 100,800 | +71.4% | 0.05% | +104.2% |
| Q2 2017 | $370,000 | – | 58,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |